StockGuru Spotlight on Stellar Biotechnologies Inc.
(Symbol: SBOTF)
Help us update information on this company. Email any updates to: [email protected]
About Stellar Biotechnologies Inc.:
Stellar Biotechnologies, Inc. (TSX-V: KLH) (OTCQB: SBOTF) is the world leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. KLH is both an active pharmaceutical ingredient (API) in many new immunotherapies (targeting cancer, infectious diseases, and immune disorders) as well as a finished product for measuring immune system status. Stellar is unique in its proprietary methods, facilities, and KLH technology. We are committed to meeting the growing demand for commercial-scale GMP-grade KLH, ensuring environmentally sound KLH production, and developing KLH-based immunotherapies. nTo learn more visit www.StellarBiotech.com and www.KLHSite.com
Where it is located:
332 E. Scott Street
Port Hueneme, CA
93041
United States
Key Executive Contact:
Herbert Chow
CTO
Ninety Day Volume:
539089 (as of date of publication)
Ninety Day Dollar Volume:
$671,705
Share Information:
78181250 shares as of 2014-08-29
Corporate Information:
State Incorporated: BC
Country Incorporated: CAN
Contact, Website and Social Media for Stellar Biotechnologies Inc.:
Shown Where Available
Website: http://www.stellarbiotechnologies.com
Facebook: https://www.facebook.com/StellarBiotech
Twitter:
LinkedIn: http://www.linkedin.com/company/stellar-biotechnologies-inc-
Telephone: (805) 488-2800
Email: [email protected]
Investor Relations for Stellar Biotechnologies Inc.: